Analysis of Hepatic Artery Infusion (HAI) Chemotherapy Using Randomized Trials of Floxuridine (FUDR) for Colon Cancer Patients with Multiple Liver Metastases
Colorectal cancer (CRC) is one of the leading causes of cancer-related death, with most of the people who have the disease developing numerous liver metastases. Sixty percent of colon cancer patients have liver metastases. Only 25% of those with resectable hepatic metastases are alive, and recurrenc...
Saved in:
Main Author: | Yuanming Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2022/3546455 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern Prospection for Hepatic Arterial Infusion Chemotherapy in Malignancies with Liver Metastases
by: Yi-Hsin Liang, et al.
Published: (2013-01-01) -
Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma
by: Yu-zhe Cao, et al.
Published: (2024-11-01) -
Single‐Nucleus and Spatial Transcriptome Profiling Delineates the Multicellular Ecosystem in Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy
by: YeXing Huang, et al.
Published: (2025-02-01) -
Multiple Cutaneous Metastases as Initial Presentation in Advanced Colon Cancer
by: Sudheer Nambiar, et al.
Published: (2018-01-01) -
Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases
by: Maartje A. J. van den Broek, et al.
Published: (2009-01-01)